Table 2.
t 0 (n = 38) | t 30 (n = 37) | t 60 (n = 36) | |
---|---|---|---|
UFH (IU/ml) | 0.128 (<0.04–3.064) | 0.418 (<0.04–0.864) | 0.340 (<0.04–0.712) |
POCT INR | 1.9 (1.2–4.4) | 2.0 (1.2–4.0) | 2.1 (1.2–4.4) |
Plasma INR | 1.85 (1.20–>28) | 2.04 (1.26–3.64) | 2.00 (1.21–3.41) |
t 0 (n = 38) | t 30 (n = 37) | t 60 (n = 36) | |
---|---|---|---|
UFH (IU/ml) | 0.128 (<0.04–3.064) | 0.418 (<0.04–0.864) | 0.340 (<0.04–0.712) |
POCT INR | 1.9 (1.2–4.4) | 2.0 (1.2–4.0) | 2.1 (1.2–4.4) |
Plasma INR | 1.85 (1.20–>28) | 2.04 (1.26–3.64) | 2.00 (1.21–3.41) |